MyNewOptions: An Online Study of Reproductive Life Planning and Contraceptive Action Planning

Sponsor
Milton S. Hershey Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT02100124
Collaborator
Patient-Centered Outcomes Research Institute (Other)
987
1
3
29
34

Study Details

Study Description

Brief Summary

The purpose of this web-based study is to determine whether reproductive life planning (RLP), with or without contraceptive action planning (RLP+), will result in reduced risk of unintended pregnancy when compared to an information-only control group.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Reproductive Life Planning (RLP)
  • Behavioral: Contraceptive Action Planning
  • Behavioral: Contraception information
N/A

Detailed Description

Most US families want 2 children, resulting in the average woman spending 3 decades of her life trying to avoid pregnancy. However, most women have at least one unintended pregnancy, resulting in 1.5 million abortions and 1.7 million unintended births annually. Women and couples try to avoid unintended pregnancy for a range of personal, social, and economic reasons, but also due to the increased physical and mental health effects for children that result from unintended pregnancy. Healthcare reform now requires that private health insurance companies cover all FDA-approved contraceptive methods with no copays or deductibles to the patient, creating a great opportunity for women with health insurance to get contraceptive methods they previously could not afford. In this study, women with health insurance will be randomly assigned to one of three groups: (1) Reproductive Life Planning (RLP)-women will complete a reproductive life plan that guides them to think about if and when they would want any future pregnancies, and to determine what contraceptive method(s) are best suited to them; (2) Reproductive Life Planning Plus (RLP+) which additionally includes "if-then planning," where women determine what they will do when they encounter difficult situations that make it difficult to use their contraceptive method perfectly; or (3) an information-only control group. The online format of the study allows for the potential of wide dissemination. The RLP and RLP+ interventions are expected to result in greater likelihood of contraceptive use, continuity of contraceptive use, and contraceptive adherence, and thus reduce overall risk of unintended pregnancy.

Study Design

Study Type:
Interventional
Actual Enrollment :
987 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Prevention
Official Title:
Reducing Unintended Pregnancies Through Reproductive Life Planning and Contraceptive Action Planning
Study Start Date :
Apr 1, 2014
Actual Primary Completion Date :
Sep 1, 2016
Actual Study Completion Date :
Sep 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Reproductive Life Planning (RLP)

RLP is an online adaptation of the Centers for Disease Control and Prevention (CDC) reproductive life planning toll that guides women to identify their reproductive goals and individual requirements for contraception.

Behavioral: Reproductive Life Planning (RLP)

Behavioral: Contraception information

Experimental: Reproductive Life Planning Plus (RLP+)

RLP+ additionally includes contraceptive action planning, aimed at helping women select solutions for potential problems they may encounter with contraceptive adherence.

Behavioral: Reproductive Life Planning (RLP)

Behavioral: Contraceptive Action Planning

Behavioral: Contraception information

Active Comparator: Information-only control

The information-only control will deliver on-line information about their contraceptive benefits coverage and information about all FDA-approved contraceptive methods.

Behavioral: Contraception information

Outcome Measures

Primary Outcome Measures

  1. Contraceptive Use [24 months]

    Percentage of surveys with any contraceptive use

Secondary Outcome Measures

  1. Effectiveness of Contraceptive Method [24 months]

    Percentage of surveys where most effective contraceptive method used

  2. Contraceptive Method Satisfaction [24 months]

    percentage of surveys where very satisfied with contraceptive method

  3. Contraceptive Adherence [24 months]

    Percentage of surveys where contraceptive adherence was high

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • not currently pregnant

  • sexually active with a male partner in the past 6 months OR anticipate being sexually active with a male partner in the next 6 months

  • does not intend pregnancy in the next 12 months

  • has Internet access and email address

Exclusion Criteria:
  • tubal sterilization

  • hysterectomy

  • partner with vasectomy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Penn State College of Medicine Hershey Pennsylvania United States 17033

Sponsors and Collaborators

  • Milton S. Hershey Medical Center
  • Patient-Centered Outcomes Research Institute

Investigators

  • Principal Investigator: Cynthia H Chuang, MD, MSc, Penn State College of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Cynthia Chuang, Associate Professor of Medicine and Public Health Sciences, Milton S. Hershey Medical Center
ClinicalTrials.gov Identifier:
NCT02100124
Other Study ID Numbers:
  • CD-1304-6117
  • CD-1304-6117
First Posted:
Mar 31, 2014
Last Update Posted:
Jul 11, 2018
Last Verified:
Sep 1, 2017
Keywords provided by Cynthia Chuang, Associate Professor of Medicine and Public Health Sciences, Milton S. Hershey Medical Center
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Reproductive Life Planning (RLP) Reproductive Life Planning Plus (RLP+) Information-only Control
Arm/Group Description RLP is an online adaptation of the Centers for Disease Control and Prevention (CDC) reproductive life planning toll that guides women to identify their reproductive goals and individual requirements for contraception. Reproductive Life Planning (RLP) Contraception information RLP+ additionally includes contraceptive action planning, aimed at helping women select solutions for potential problems they may encounter with contraceptive adherence. Reproductive Life Planning (RLP) Contraceptive Action Planning Contraception information The information-only control will deliver on-line information about their contraceptive benefits coverage and information about all FDA-approved contraceptive methods. Contraception information
Period Title: Overall Study
STARTED 329 329 326
COMPLETED 323 318 323
NOT COMPLETED 6 11 3

Baseline Characteristics

Arm/Group Title Reproductive Life Planning (RLP) Reproductive Life Planning Plus (RLP+) Information-only Control Total
Arm/Group Description RLP is an online adaptation of the Centers for Disease Control and Prevention (CDC) reproductive life planning toll that guides women to identify their reproductive goals and individual requirements for contraception. Reproductive Life Planning (RLP) Contraception information RLP+ additionally includes contraceptive action planning, aimed at helping women select solutions for potential problems they may encounter with contraceptive adherence. Reproductive Life Planning (RLP) Contraceptive Action Planning Contraception information The information-only control will deliver on-line information about their contraceptive benefits coverage and information about all FDA-approved contraceptive methods. Contraception information Total of all reporting groups
Overall Participants 329 329 326 984
Age (Count of Participants)
<=18 years
0
0%
0
0%
0
0%
0
0%
Between 18 and 65 years
329
100%
329
100%
326
100%
984
100%
>=65 years
0
0%
0
0%
0
0%
0
0%
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
27.02
(5.95)
27.08
(6.13)
27.28
(5.92)
27.13
(5.99)
Sex: Female, Male (Count of Participants)
Female
329
100%
329
100%
326
100%
984
100%
Male
0
0%
0
0%
0
0%
0
0%
Region of Enrollment (participants) [Number]
United States
329
100%
329
100%
326
100%
984
100%

Outcome Measures

1. Primary Outcome
Title Contraceptive Use
Description Percentage of surveys with any contraceptive use
Time Frame 24 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Reproductive Life Planning (RLP) Reproductive Life Planning Plus (RLP+) Information-only Control
Arm/Group Description RLP is an online adaptation of the Centers for Disease Control and Prevention (CDC) reproductive life planning toll that guides women to identify their reproductive goals and individual requirements for contraception. Reproductive Life Planning (RLP) Contraception information RLP+ additionally includes contraceptive action planning, aimed at helping women select solutions for potential problems they may encounter with contraceptive adherence. Reproductive Life Planning (RLP) Contraceptive Action Planning Contraception information The information-only control will deliver on-line information about their contraceptive benefits coverage and information about all FDA-approved contraceptive methods. Contraception information
Measure Participants 308 298 312
Mean (Standard Deviation) [percentage of surveys]
93.43
(20.59)
94.46
(20.53)
94.10
(19.80)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Reproductive Life Planning (RLP), Information-only Control
Comments
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value 1.0
Comments
Method Regression, Logistic
Comments
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 0.87
Confidence Interval (2-Sided) 95%
0.56 to 1.36
Parameter Dispersion Type:
Value:
Estimation Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Reproductive Life Planning Plus (RLP+), Information-only Control
Comments
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value 1.0
Comments
Method Regression, Logistic
Comments
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 1.13
Confidence Interval (2-Sided) 95%
0.70 to 1.83
Parameter Dispersion Type:
Value:
Estimation Comments
Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Reproductive Life Planning (RLP), Reproductive Life Planning Plus (RLP+)
Comments
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value 0.53
Comments
Method Regression, Logistic
Comments
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 1.30
Confidence Interval (2-Sided) 95%
0.82 to 2.08
Parameter Dispersion Type:
Value:
Estimation Comments
2. Secondary Outcome
Title Effectiveness of Contraceptive Method
Description Percentage of surveys where most effective contraceptive method used
Time Frame 24 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Reproductive Life Planning (RLP) Reproductive Life Planning Plus (RLP+) Information-only Control
Arm/Group Description RLP is an online adaptation of the Centers for Disease Control and Prevention (CDC) reproductive life planning toll that guides women to identify their reproductive goals and individual requirements for contraception. Reproductive Life Planning (RLP) Contraception information RLP+ additionally includes contraceptive action planning, aimed at helping women select solutions for potential problems they may encounter with contraceptive adherence. Reproductive Life Planning (RLP) Contraceptive Action Planning Contraception information The information-only control will deliver on-line information about their contraceptive benefits coverage and information about all FDA-approved contraceptive methods. Contraception information
Measure Participants 308 298 312
Mean (Standard Deviation) [percentage of surveys]
60.66
(45.11)
63.93
(43.91)
63.19
(43.22)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Reproductive Life Planning (RLP), Information-only Control
Comments
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value 0.48
Comments
Method Regression, Logistic
Comments
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 0.88
Confidence Interval (2-Sided) 95%
0.71 to 1.09
Parameter Dispersion Type:
Value:
Estimation Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Reproductive Life Planning Plus (RLP+), Information-only Control
Comments
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value 1.0
Comments
Method Regression, Logistic
Comments
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 1.08
Confidence Interval (2-Sided) 95%
0.87 to 1.35
Parameter Dispersion Type:
Value:
Estimation Comments
Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Reproductive Life Planning (RLP), Reproductive Life Planning Plus (RLP+)
Comments
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value 0.07
Comments
Method Regression, Logistic
Comments
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 1.23
Confidence Interval (2-Sided) 95%
0.99 to 1.53
Parameter Dispersion Type:
Value:
Estimation Comments
3. Secondary Outcome
Title Contraceptive Method Satisfaction
Description percentage of surveys where very satisfied with contraceptive method
Time Frame 24 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Reproductive Life Planning (RLP) Reproductive Life Planning Plus (RLP+) Information-only Control
Arm/Group Description RLP is an online adaptation of the Centers for Disease Control and Prevention (CDC) reproductive life planning toll that guides women to identify their reproductive goals and individual requirements for contraception. Reproductive Life Planning (RLP) Contraception information RLP+ additionally includes contraceptive action planning, aimed at helping women select solutions for potential problems they may encounter with contraceptive adherence. Reproductive Life Planning (RLP) Contraceptive Action Planning Contraception information The information-only control will deliver on-line information about their contraceptive benefits coverage and information about all FDA-approved contraceptive methods. Contraception information
Measure Participants 299 289 304
Mean (Standard Deviation) [percentage of surveys]
58.22
(39.39)
57.09
(41.13)
57.70
(39.57)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Reproductive Life Planning (RLP), Information-only Control
Comments
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value 1.0
Comments
Method Regression, Logistic
Comments
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 1.04
Confidence Interval (2-Sided) 95%
0.84 to 1.29
Parameter Dispersion Type:
Value:
Estimation Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Reproductive Life Planning Plus (RLP+), Information-only Control
Comments
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value 1.0
Comments
Method Regression, Logistic
Comments
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 1.02
Confidence Interval (2-Sided) 95%
0.82 to 1.26
Parameter Dispersion Type:
Value:
Estimation Comments
Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Reproductive Life Planning (RLP), Reproductive Life Planning Plus (RLP+)
Comments
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value 1.0
Comments
Method Regression, Logistic
Comments
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 0.98
Confidence Interval (2-Sided) 95%
0.79 to 1.22
Parameter Dispersion Type:
Value:
Estimation Comments
4. Secondary Outcome
Title Contraceptive Adherence
Description Percentage of surveys where contraceptive adherence was high
Time Frame 24 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Reproductive Life Planning (RLP) Reproductive Life Planning Plus (RLP+) Information-only Control
Arm/Group Description RLP is an online adaptation of the Centers for Disease Control and Prevention (CDC) reproductive life planning toll that guides women to identify their reproductive goals and individual requirements for contraception. Reproductive Life Planning (RLP) Contraception information RLP+ additionally includes contraceptive action planning, aimed at helping women select solutions for potential problems they may encounter with contraceptive adherence. Reproductive Life Planning (RLP) Contraceptive Action Planning Contraception information The information-only control will deliver on-line information about their contraceptive benefits coverage and information about all FDA-approved contraceptive methods. Contraception information
Measure Participants 299 289 304
Mean (Standard Deviation) [percentage of surveys]
74.02
(34.19)
73.27
(35.54)
76.37
(32.69)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Reproductive Life Planning (RLP), Information-only Control
Comments
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value 1.0
Comments
Method Regression, Logistic
Comments
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 1.07
Confidence Interval (2-Sided) 95%
0.83 to 1.37
Parameter Dispersion Type:
Value:
Estimation Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Reproductive Life Planning Plus (RLP+), Information-only Control
Comments
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value 1.0
Comments
Method Regression, Logistic
Comments
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 1.04
Confidence Interval (2-Sided) 95%
0.81 to 1.33
Parameter Dispersion Type:
Value:
Estimation Comments
Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Reproductive Life Planning (RLP), Reproductive Life Planning Plus (RLP+)
Comments
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value 1.0
Comments
Method Regression, Logistic
Comments
Method of Estimation Estimation Parameter Odds Ratio (OR)
Estimated Value 0.97
Confidence Interval (2-Sided) 95%
0.75 to 1.25
Parameter Dispersion Type:
Value:
Estimation Comments

Adverse Events

Time Frame 1 year, 5 months
Adverse Event Reporting Description
Arm/Group Title Reproductive Life Planning (RLP) Reproductive Life Planning Plus (RLP+) Information-only Control
Arm/Group Description RLP is an online adaptation of the Centers for Disease Control and Prevention (CDC) reproductive life planning toll that guides women to identify their reproductive goals and individual requirements for contraception. Reproductive Life Planning (RLP) Contraception information RLP+ additionally includes contraceptive action planning, aimed at helping women select solutions for potential problems they may encounter with contraceptive adherence. Reproductive Life Planning (RLP) Contraceptive Action Planning Contraception information The information-only control will deliver on-line information about their contraceptive benefits coverage and information about all FDA-approved contraceptive methods. Contraception information
All Cause Mortality
Reproductive Life Planning (RLP) Reproductive Life Planning Plus (RLP+) Information-only Control
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/329 (0%) 0/329 (0%) 0/326 (0%)
Serious Adverse Events
Reproductive Life Planning (RLP) Reproductive Life Planning Plus (RLP+) Information-only Control
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/329 (0%) 0/329 (0%) 0/326 (0%)
Other (Not Including Serious) Adverse Events
Reproductive Life Planning (RLP) Reproductive Life Planning Plus (RLP+) Information-only Control
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/329 (0%) 0/329 (0%) 0/326 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Cynthia Chuang
Organization Penn State College of Medicine
Phone 7175318161
Email CChuang@psu.edu
Responsible Party:
Cynthia Chuang, Associate Professor of Medicine and Public Health Sciences, Milton S. Hershey Medical Center
ClinicalTrials.gov Identifier:
NCT02100124
Other Study ID Numbers:
  • CD-1304-6117
  • CD-1304-6117
First Posted:
Mar 31, 2014
Last Update Posted:
Jul 11, 2018
Last Verified:
Sep 1, 2017